ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.

Alessandro Canella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.